Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2969907 | The Journal of Heart and Lung Transplantation | 2014 | 32 Pages |
Abstract
A “survival paradox” exists among ACHD recipients, whose high early mortality is balanced by better long-term survival in those who survive the early hazard phase after HTx. A high mortality risk after cardiac re-transplantation in this group of patients suggests that this treatment option should only be considered in carefully selected ACHD HTx recipients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Luke J. MBBS, PhD, Leah B. PhD, Anne I. MD, Joseph MD, MPH, Heather J. MD, MHSc,